Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis.

Curtis, Jeffrey R; Emery, Paul; Downie, Bryan; Zhong, Yan; Liu, Jinfeng; Han, Ling; Hawtin, Rachael E; Burmester, Gerd Rüdiger

Curtis, Jeffrey R; Emery, Paul; Downie, Bryan; Zhong, Yan; Liu, Jinfeng; Han, Ling; Hawtin, Rachael E; Burmester, Gerd Rüdiger.

Afiliação

Curtis JR; Division of Clinical Immunology and Rheumatology, Faculty Office Tower, University of Alabama at Birmingham, 510 20th St S #834, Birmingham, AL, 35294, USA. jrcurtis@uabmc.edu.
Emery P; Leeds NIHR Biomedical Research Centre, LTHT, and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
Downie B; Gilead Sciences, Inc, Foster City, CA, USA.
Zhong Y; Gilead Sciences, Inc, Foster City, CA, USA.
Liu J; Gilead Sciences, Inc, Foster City, CA, USA.
Han L; Gilead Sciences, Inc, Foster City, CA, USA.
Hawtin RE; Gilead Sciences, Inc, Foster City, CA, USA.
Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Rheumatol Ther ; 11(1): 177-189, 2024 Feb.

Article em En | MEDLINE | ID: mdl-38057656